|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
| City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
||||||||
| TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 7/19/2018 5:34:15 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S 3158 - HRSA funding-FY 2019 HHS Appropriations: Funding for access to primary care, health professional training grants, Title X family planning.
S. 3158 - CDC funding-FY 2019 HHS Appropriations: Chronic Disease Prevention & Health Promotion, Immunization.
S. 3158 - Rural Health programs funding-FY 2019 HHS Appropriations: Eliminate disparities of access to quality care for all populations.
S. 1358 - Increased overall spending FY19 HHS Appropriations: AAFP FY 2019 federal spending priorities for primary care training, research & access.
S. 3158 - Gun Violence Prevention CDC funding-FY 2019 HHS Appropriation:Gun violence is a public health emergency.
S 3158 - AHRQ funding-FY 2019 HHS Appropriations:Primary Care Research, US Preventive Services Task Force.
S. 3158 -CMS funding-FY 2019 HHS Appropriations S 3158 & House draft: Support effective, efficient management of Medicare, Medicaid, CHIP & Marketplaces.
No Bill No. - Oppose tobacco riders in Ag bill & cut to CDCs Office on Smoking and Health: Public Health/Tobacco Control.
No Bill No. - National Health Services Corps.: Sustainable funding for NHSC to provide access and debt relief.
No Bill No. - Public Service Loan Forgiveness Program: Medical Student Debt relief.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S. 3014 - Rural Physician Workforce Production Act: Graduate Medical Education reform, rural physician workforce; Seek co-sponsors on rural GME bill; seek House sponsors; Advocated for the Rural Physician Workforce Production Act; Seek Co-sponsors on legislation to amend the title XVIII of the Social Security Act to support rural residency training funding.
S 3158 - HRSA funding-FY 2019 HHS Appropriations: Funding for access to primary care, health professional training grants, Title X family planning.
S. 3158 - Increased overall spending FY19 HHS Appropriations: AAFP FY 2019 federal spending priorities for primary care training, research & access.
No Bill No. - National Health Services Corps.: Sustainable funding for NHSC to provide access and debt relief.
No Bill No. - Public Service Loan Forgiveness Program: Medical Student Debt relief.
No Bill No. - Concern with Public Service Loan Forgiveness Program: Physician training and PSLF programs.
No Bill No.- Congressional Primary Care Caucus: Urge members to join the Primary Care Caucus to achieve the triple aim in healthcare.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
Legislative Counsel to Rep. Jim McDermott |
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Hall |
|
Legislative Counsel to US Senator Mark Dayton |
|
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 1112/HR 1318 - Maternal Accountability Act/Preventing Maternal Deaths: Promoted preventing maternal mortality.
S. 2691 - Opioid Crisis Accountability Act - Responding to Senate inquiry on restricting the marketing and distribution of opioids.
S. 2704 - Medicare Beneficiary Opioid Addiction Treatment: Responding to senate inquiry in support of Opioid treatment.
S 2852, S. 2852 & House Draft: ASPR & Pandemic & All Hazards Preparedness Act reauthorization: Public Health preparedness.
S. 3014 - Rural Physician Workforce Production Act: Graduate Medical Education reform, rural physician workforce; seek co-sponsors on rural GME bill; seek House sponsors; Seek Co-sponsors on legislation to amend the title XVIII of the Social Security Act to support rural residency training funding.
S 3158 - HRSA funding-FY 2019 HHS Appropriations: Funding for access to primary care, health professional training grants, Title X family planning.
S. 3158 - CDC funding-FY 2019 HHS Appropriations: Chronic Disease Prevention & Health Promotion, Immunization.
S. 3158 - Increased overall spending FY19 HHS Appropriations: AAFP FY 2019 federal spending priorities for primary care training, research & access.
S. 3158 - Rural Health programs funding-FY 2019 HHS Appropriations: Eliminate disparities of access to quality care for all populations.
S. 3158 - Gun Violence Prevention CDC funding-FY 2019 HHS Appropriation:Gun violence is a public health emergency.
S 3158 - AHRQ funding-FY 2019 HHS Appropriations:Primary Care Research, US Preventive Services Task Force.
S. 3158 - SAMHSA funding-FY 2019 HHS Appropriations: Provide adequate resources for substance abuse treatment.
S. 3158 - CMS funding-FY 2019 HHS Appropriations S 3158 & House draft: Support effective, efficient management of Medicare, Medicaid, CHIP & Marketplaces.
HR 2 - Agriculture Improvement Act: Issued concerns about the SNAP cuts and health care policies.
HR 5858 - Primary Care Patient Protection Act: Seek co-sponsors for legislation to require coverage without a deductible of certain primary care services by high deductible health plans.
H.R. 6310; H.R. 6317 - Direct Primary Care: Advocate for co-sponsorship of bill to allow Americans with HSAs to use their accounts to pay for DPC arrangements.
No Bill No. - Opioid Epidemic: Support evidence based approaches to curb opioid abuse; Commented on E&C Bills. Advocated for the ACE Research Act and CONNECTIONS Act.
No Bill No. - Overcoming Gaps in the Treatment of Mental Illness Research: Improved mental health services.
No Bill No. - Shoulder Injury Related to Vaccine Administration: Responding to Senate inquiry on vaccine injury prevention.
No Bill No. - Paid sick leave to benefit American workers: Public Health.
No Bill No. - Oppose tobacco riders in Ag bill & cut to CDCs Office on Smoking and Health: Public Health/Tobacco Control.
No Bill No. - National Health Services Corps.: Sustainable funding for NHSC to provide access and debt relief.
No Bill No. - Administrative Burden: Administrative simplification to stem physician burnout; Advocate for end to E/M documentation guidelines, AUC, etc. in WM Red Tape Initiative.
No Bill No. - Advanced Primary Care Alternative Payment Model: New Medicare alternative payment model; Seek co-signors on letter to HHS on APC-APM payment model.
No Bill No. - HHS on the HPV draft paper: How to improve HPV vaccination rates.
No Bill No.- Congressional Primary Care Caucus: Urge members to join the Primary Care Caucus to achieve the triple aim in healthcare.
No Bill No. - Direct Primary Care:advocate for co-sponsorship of bill to allow Americans with HSAs to use DPCs.
No Bill No. - Insurance Market Stabilization: Outreach on ACA policies and possible market stabilization.
No Bill No. - Drug Pricing: Provided feedback ont he CREATES Act and PACED Act. Drafted a drug pricing letter.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
Legislative Counsel to Rep. Jim McDermott |
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
|
Robert |
Hall |
|
Legislative Counsel to US Senator Mark Dayton |
|
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 2704 - Medicare Beneficiary Opioid Addiction Treatment: Responding to senate inquiry in support of Opioid treatment.
S. 3014 - Rural Physician Workforce Production Act: Graduate Medical Education reform, rural physician workforce; seek co-sponsors on rural GME bill; seek House sponsors; seek co-sponsors on legislation to amend the title XVII of the Social Security Act to support rural residency training funding.
S. 3158 - Increased overall spending FY19 HHS Appropriations: AAFP FY 2019 federal spending priorities for primary care training, research & access.
S. 3158 -CMS funding-FY 2019 HHS Appropriations S 3158 & House draft: Support effective, efficient management of Medicare, Medicaid, CHIP & Marketplaces.
No Bill No. - Opioid Epidemic: Evidence based approaches to curb opioid abuse; Commented on E&C Bills. Advocated for the ACE Research Act and CONNECTIONS Act.
No Bill No. - Overcoming Gaps in the Treatment of Mental Illness Research: Improved mental health services.
No Bill No. - Advanced Primary Care Alternative Payment Model: New Medicare alternative payment model.
Mo Bill No. - CMS on documentation burden listening session: How to ensure access to Medicaid Services.
No Bill No. - CMS on access to Medicaid Services: How to ensure access to Medicaid Services.
No Bill No. - CMS on RFI Direct Provider contracting models: How CMS should focus on the APC-APM but also implement the AAFP's DPC model; Seek co-signors on letter to HHS on APC-APM payment model.
No Bill No.- Congressional Primary Care Caucus: Urge members to join the Caucus and support Primary Care to achieve the triple aim in healthcare.
No Bill No. - Administrative Burden: Advocate for end to E/M documentation guidelines, AUC, etc. in WM Red Tape Relief initiative.
No Bill No. - Insurance Market Stabilization: Outreach on ACA policies and possible market stabilization.
No Bill No. - Drug Pricing: Provided feedback on the CREATES Act and PACED Act. Drafted a drug pricing letter.
No Bill No. - MACRA/Advanced Primary Care APM: Raised awareness of the AAFP's primary care payment model.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
|
Robert |
Hall |
|
Legislative Counsel to US Senator Mark Dayton |
|
Andrew |
Adair |
|
Legislative Counsel to Rep. Jim McDermott |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
S. 2691 - Opioid Crisis Accountability Act - Responding to Senate inquiry on restricting the marketing and distribution of opioids.
S. 2704 - Medicare Beneficiary Opioid Addiction Treatment: Responding to senate inquiry in support of Opioid treatment.
S. 3158 - SAMHSA funding-FY 2019 HHS Appropriations: Provide adequate resources for substance abuse treatment.
No Bill No. - Opioid Epidemic: Support evidence-based approaches to curb opioid abuse.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst & Director |
|
Mark |
Cribben |
|
|
|
Robert |
Hall |
|
Legislative Counsel to US Senator Mark Dayton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
No Bill No. - Respond to HHS on short-term, limited duration insurance: Meaningful insurance isn't short term.
HR 5858 - Primary Care Patient Protection Act: Seek co-sponsors for legislation to require coverage without a deductible of certain primary care services by high deductible health plans.
H.R. 6310; H.R. 6317 - Direct Primary Care: Advocate for co-sponsorship of bill to allow Americans with HSAs to use their accounts to pay for DPC arrangements.
No Bill No. - Direct Primary Care:advocate for co-sponsorship of bill to allow Americans with HSAs to use DPCs.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Robert |
Hall |
|
Legislative Counsel to US Senator Mark Dayton |
|
Robert |
Bennett |
|
Health Insurance Specialist, CMS Office of Communication |
|
Andrew |
Adair |
|
Legislative Counsel to Rep. Jim McDermott |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
No Bill No. - Oppose tobacco riders in Ag bill and cut to CDC's office on Smoking and Health: Public Health tobacco control.
No Bill No. - Tobacco use in Head Start Programs.
No Bill No. - RFI "nicotine steering committee": What FDA should regulate regarding nicotine.
No Bill No. - FDA on premium cigars: Regulate premium cigars.
No Bill No. - FDA on flavor products: Regulate favor products.
No Bill No. - FDA on nicotine standards: Combustible nicotine standard.
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
Health Insurance Specialist , CMS Office of Communication |
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst & Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S. 2704 - Medicare Beneficiary Opioid Addiction Treatment: Responding to senate inquiry in support of Opioid treatment.
No Bill No. - Opioid Epidemic: Evidence based approaches to curb opioid abuse; Commented on E&C Bills. Advocated for the ACE Research Act and CONNECTIONS Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder. |
|
Mark |
Cribben |
|
|
|
Robert |
Hall |
|
Legislative Counsel to US Senator Mark Dayton |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
No Bill No. - EPA on carbon pollution emission guidelines: EPA should change carbon pollution standards.
17. House(s) of Congress and Federal agencies Check if None
Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Bennett |
|
Health Insurance Specialist, CMS Office of Communication |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
S. 2691 - Opioid Crisis Accountability Act - Responding to Senate inquiry on restricting the marketing and distribution of opioids.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
No Bill No. - Paid sick leave to benefit American workers: Public Health.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
S. 3158 - Gun Violence Prevention CDC funding-FY 2019 HHS Appropriation:Gun violence is a public health emergency.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
S 2852, S. 2852 & House Draft: ASPR & Pandemic & All Hazards Preparedness Act reauthorization: Public Health preparedness.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
S. 1112/HR 1318 - Maternal Accountability Act/Preventing Maternal Deaths: Promoted preventing maternal mortality.
S. 3158 - Gun Violence Prevention CDC funding-FY 2019 HHS Appropriation:Gun violence is a public health emergency.
HR 2 - Agriculture Improvement Act: Issued concerns about the SNAP cuts and health care policies.
No Bill No. - National Institute on Aging into care, treatment, fall prevention in aged: Improving care and quality of life for older adults.
No Bill No. - Opioids: Commented on E&C Bills. Advocated for the ACE Research Act and CONNECTIONS Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst and Director |
|
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
No Bill No. - Opioids: Commented on E&C Bills. Asvocated for the ACE Research Act and CONNECTIONS Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
HR 2 - Agriculture Improvement Act: Issued concerns about the SNAP cuts and health care policies.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code WEL
16. Specific lobbying issues
HR 2 - Agriculture Improvement Act: Issued concerns about the SNAP cuts and health care policies.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
Legislative Assistant, Office of U.S. Rep. Jose Serrano; Legislative Assistant, Office of U.S. Rep. Steny Hoyer; Legislative Director, Office of U.S. Rep. Barbara Lee; Legislative Assistant, Office of U.S. Rep.Glen Browder |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |